NJ State Employees Deferred Compensation Plan - PROTALIX BIOTHERAPEUTICS INC ownership

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2015$78,000
+9.9%
40,0000.0%0.02%
+7.1%
Q1 2015$71,000
-4.1%
40,0000.0%0.01%0.0%
Q4 2014$74,000
-23.7%
40,0000.0%0.01%
-30.0%
Q3 2014$97,000
-33.6%
40,0000.0%0.02%
-31.0%
Q2 2014$146,000
-20.2%
40,0000.0%0.03%
-23.7%
Q1 2014$183,00040,0000.04%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,825,000$1,206,0000.39%
Zhang Financial LLC 45,000$33,0000.02%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 472,553$313,0000.01%
MEITAV INVESTMENT HOUSE LTD 127,062$85,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 324,479$215,000,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$200,0000.00%
Renaissance Technologies 1,993,500$1,318,0000.00%
WEDBUSH SECURITIES INC 15,000$10,0000.00%
TWO SIGMA SECURITIES, LLC 57,127$38,0000.00%
Psagot Value Holdings Ltd. 29,193$20,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders